Capromab Pendetide imaging of prostate cancer

Capromab Pendetide imaging illustrates the successful translation of monoclonal antibody technology from the laboratory to the clinic. It provides a means of identifying otherwise occult soft tissue metastases in patients with adenocarcinoma of the prostate. When utilized with other clinical, pathol...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer biotherapy & radiopharmaceuticals 2000-04, Vol.15 (2), p.131-140
Hauptverfasser:	Haseman, M K, Rosenthal, S A, Polascik, T J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - diagnostic imaging Adenocarcinoma - pathology Adenocarcinoma - radiotherapy Adenocarcinoma - secondary Adenocarcinoma - surgery Alkaline Phosphatase - blood Antibodies, Monoclonal Biomarkers, Tumor - blood Bone Neoplasms - diagnostic imaging Bone Neoplasms - secondary Combined Modality Therapy Evaluation Studies as Topic Humans Lymph Node Excision Lymphatic Metastasis Male Neoplasm Metastasis Neoplasm Proteins - blood Neoplasm Recurrence, Local Neoplasm Staging Neoplasm, Residual Preoperative Care Prostate-Specific Antigen - blood Prostatectomy Prostatic Neoplasms - diagnostic imaging Prostatic Neoplasms - pathology Prostatic Neoplasms - radiotherapy Prostatic Neoplasms - surgery Radioimmunodetection Radioisotope Teletherapy Salvage Therapy Sensitivity and Specificity Tomography, Emission-Computed, Single-Photon
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!